FUNCTIONAL AREAS – Page 19

PPQ acceptance criteria not met during system upgrades – regulatory deficiency analysis and remediation roadmap

Identifying the initial signs of PPQ acceptance criteria not being met is crucial for timely intervention. Symptoms may manifest as unexpected variability in output or performance metrics, concerns raised during…

Incomplete impact assessment during tech transfer validation – regulatory deficiency analysis and remediation roadmap

Identifying signals of an incomplete impact assessment during tech transfer validation is the first step in investigation and remediation. Practitioners should be alert for the following:Click to read the full…

Revalidation not triggered after change during change control review – how to prevent repeat validation failures

Preventing Validation Failures Due to Untriggered Revalidation After Change Control Review In pharmaceutical manufacturing, deviations from established processes, especially regarding validation protocols, can have significant implications for product quality and…

Revalidation not triggered after change during system upgrades – documentation pitfalls that trigger 483 observations

Identifying the right symptoms at the onset of a potential investigation is vital. Here are key signals that may indicate revalidation has not been appropriately triggered post-change during system upgrades:Click…

Traceability matrix gaps during tech transfer validation – how to rebuild the evidence package for inspectors

Identifying the symptoms of gaps in traceability matrices is critical for timely action. Common signals observed may include:Click to read the full article.

Inadequate worst-case justification during tech transfer validation – regulatory deficiency analysis and remediation roadmap

Recognizing the early signs of inadequate worst-case justification is essential in ensuring a robust tech transfer process. Symptoms may include:Click to read the full article.

Periodic review overdue during validation lifecycle – regulatory deficiency analysis and remediation roadmap

When a periodic review due date is missed, a variety of symptoms or signals may surface, requiring immediate attention. These include:Click to read the full article.

Equipment qualification incomplete during inspection readiness – how to rebuild the evidence package for inspectors

The first step in any deviation investigation is to identify the symptoms or signals that indicate potential issues with equipment qualification. When equipment qualification is incomplete, clear indicators may arise:Click…

Equipment qualification incomplete during tech transfer validation – risk-based validation strategy aligned to FDA/EMA

Identifying the symptoms or signals of incomplete equipment qualification is the first step in addressing any issue effectively. The initial detection can be from multiple sources within the manufacturing or…

Periodic review overdue during inspection readiness – how to rebuild the evidence package for inspectors

Identifying symptoms early can prevent minor issues from escalating into major compliance risks. Some common symptoms related to overdue periodic reviews include:Click to read the full article.

PPQ acceptance criteria not met during requalification planning – documentation pitfalls that trigger 483 observations

Identifying the initial symptoms or signals on the manufacturing floor or laboratory is crucial for timely intervention. Common indicators that may suggest problems with PPQ acceptance criteria include:Click to read…

Incomplete impact assessment during inspection readiness – CAPA and revalidation plan with timelines

Recognizing the signs of incomplete impact assessments is the first step in addressing potential compliance issues. Symptoms may manifest as:Click to read the full article.